Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 316 articles:
HTML format
Text format



Single Articles


    November 2017
  1. EVERITT S, Ball D, Hicks RJ, Callahan J, et al
    Prospective Study of Serial Imaging Comparing Fluorodeoxyglucose Positron Emission Tomography (PET) and Fluorothymidine PET During Radical Chemoradiation for Non-Small Cell Lung Cancer: Reduction of Detectable Proliferation Associated With Worse Survi
    Int J Radiat Oncol Biol Phys. 2017;99:947-955.
    PubMed     Text format     Abstract available


  2. NIEDZIELSKI JS, Yang J, Mohan R, Titt U, et al
    Differences in Normal Tissue Response in the Esophagus Between Proton and Photon Radiation Therapy for Non-Small Cell Lung Cancer Using In Vivo Imaging Biomarkers.
    Int J Radiat Oncol Biol Phys. 2017;99:1013-1020.
    PubMed     Text format     Abstract available


  3. VAN DER VELDEN JM, Peters M, Verlaan JJ, Versteeg AL, et al
    Development and Internal Validation of a Clinical Risk Score to Predict Pain Response After Palliative Radiation Therapy in Patients With Bone Metastases.
    Int J Radiat Oncol Biol Phys. 2017;99:859-866.
    PubMed     Text format     Abstract available


    October 2017
  4. WIJSMAN R, Dankers FJWM, Troost EGC, Hoffmann AL, et al
    Inclusion of Incidental Radiation Dose to the Cardiac Atria and Ventricles Does Not Improve the Prediction of Radiation Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:434-441.
    PubMed     Text format     Abstract available


  5. PRABHU RS, Press RH, Patel KR, Boselli DM, et al
    Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
    Int J Radiat Oncol Biol Phys. 2017;99:459-467.
    PubMed     Text format     Abstract available


  6. VOGEL J, Lin L, Litzky LA, Berman AT, et al
    Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma.
    Int J Radiat Oncol Biol Phys. 2017;99:427-433.
    PubMed     Text format     Abstract available


  7. JOCHEMS A, Deist TM, El Naqa I, Kessler M, et al
    Developing and Validating a Survival Prediction Model for NSCLC Patients Through Distributed Learning Across 3 Countries.
    Int J Radiat Oncol Biol Phys. 2017;99:344-352.
    PubMed     Text format     Abstract available


  8. BAHIG H, Campeau MP, Lapointe A, Bedwani S, et al
    Phase 1-2 Study of Dual-Energy Computed Tomography for Assessment of Pulmonary Function in Radiation Therapy Planning.
    Int J Radiat Oncol Biol Phys. 2017;99:334-343.
    PubMed     Text format     Abstract available


  9. FAUGHT AM, Miyasaka Y, Kadoya N, Castillo R, et al
    Evaluating the Toxicity Reduction With Computed Tomographic Ventilation Functional Avoidance Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:325-333.
    PubMed     Text format     Abstract available


  10. MODIRI A, Sabouri P, Gu X, Timmerman R, et al
    Inversed-Planned Respiratory Phase Gating in Lung Conformal Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:317-324.
    PubMed     Text format     Abstract available


    September 2017
  11. ERIKSSON M, Haag P, Brzozowska B, Lipka M, et al
    Analysis of Chromatin Opening in Heterochromatic Non-Small cell Lung Cancer Tumor-Initiating Cells in Relation to DNA-Damaging Antitumor Treatment.
    Int J Radiat Oncol Biol Phys. 2017 Sep 22. pii: S0360-3016(17)33933.
    PubMed     Text format     Abstract available


  12. RONDEN MI, van Sornsen de Koste JR, Johnson C, Slotman BJ, et al
    Incidence of High-Risk Radiologic Features in Patients Without Local Recurrence After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Sep 22. pii: S0360-3016(17)33935.
    PubMed     Text format     Abstract available


  13. SUN Y, Hawkins PG, Bi N, Dess RT, et al
    Serum MicroRNA Signature Predicts Response to High-Dose Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Sep 4. pii: S0360-3016(17)33836.
    PubMed     Text format     Abstract available


  14. PATRICE GI, Lester-Coll NH, Yu JB, Amdahl J, et al
    Cost-Effectiveness of Thoracic Radiation Therapy for Extensive-Stage Small Cell Lung Cancer Using Evidence From the Chest Radiotherapy Extensive-Stage Small Cell Lung Cancer Trial (CREST).
    Int J Radiat Oncol Biol Phys. 2017 Sep 4. pii: S0360-3016(17)33838.
    PubMed     Text format     Abstract available


  15. KARKI K, Saraiya S, Hugo GD, Mukhopadhyay N, et al
    Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.
    Int J Radiat Oncol Biol Phys. 2017;99:80-89.
    PubMed     Text format     Abstract available


  16. NING MS, Tang L, Gomez DR, Xu T, et al
    Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;99:70-79.
    PubMed     Text format     Abstract available


  17. VIVEKANANDAN S, Landau DB, Counsell N, Warren DR, et al
    The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;99:51-60.
    PubMed     Text format     Abstract available


  18. DALY ME, Palma DA
    Prophylactic Cranial Irradiation for Small Cell Lung Cancer: New Insights.
    Int J Radiat Oncol Biol Phys. 2017;99:3-5.
    PubMed     Text format    


  19. CHOI CYH, Wakelee HA, Neal JW, Pinder-Schenck MC, et al
    Vorinostat and Concurrent Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases: A Phase 1 Dose Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2017;99:16-21.
    PubMed     Text format     Abstract available


  20. FAUGHT AM, Yamamoto T, Castillo R, Castillo E, et al
    Evaluating Which Dose-Function Metrics Are Most Critical for Functional-Guided Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;99:202-209.
    PubMed     Text format     Abstract available


    August 2017
  21. GORGISYAN J, Munck Af Rosenschold P, Perrin R, Persson GF, et al
    Feasibility of Pencil Beam Scanned Intensity Modulated Proton Therapy in Breath-hold for Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Aug 24. pii: S0360-3016(17)33779.
    PubMed     Text format     Abstract available


  22. MCMILLAN MT, Ojerholm E, Verma V, Higgins KA, et al
    Radiation Treatment Time and Overall Survival in Locally Advanced Non-small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:1142-1152.
    PubMed     Text format     Abstract available


  23. SHAVERDIAN N, Yoo SM, Cook R, Chang EM, et al
    Gaps in Radiation Therapy Awareness: Results From an Educational Multi-institutional Survey of US Internal Medicine Residents.
    Int J Radiat Oncol Biol Phys. 2017;98:1153-1161.
    PubMed     Text format     Abstract available


  24. KIM TH, Kim MH, Kim BJ, Park SI, et al
    Prognostic Importance of the Site of Recurrence in Patients With Metastatic Recurrent Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:1124-1131.
    PubMed     Text format     Abstract available


    July 2017
  25. FANG P, He W, Gomez DR, Hoffman KE, et al
    Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States.
    Int J Radiat Oncol Biol Phys. 2017;98:748-757.
    PubMed     Text format     Abstract available


  26. MIDDELBURG JG, Mast ME, de Kroon M, Jobsen JJ, et al
    Timed Get Up and Go Test and Geriatric 8 Scores and the Association With (Chemo-)Radiation Therapy Noncompliance and Acute Toxicity in Elderly Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2017;98:843-849.
    PubMed     Text format     Abstract available


  27. WAHL DR, Nguyen PL, Santiago M, Yousefi K, et al
    Pan-Cancer Analysis of Genomic Sequencing Among the Elderly.
    Int J Radiat Oncol Biol Phys. 2017;98:726-732.
    PubMed     Text format     Abstract available


  28. JAN N, Guy C, Reshko LB, Hugo GD, et al
    Lung and Heart Dose Variability During Radiation Therapy of Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:683-690.
    PubMed     Text format     Abstract available


  29. CHEN H, Senan S, Nossent EJ, Boldt RG, et al
    Treatment-Related Toxicity in Patients With Early-Stage Non-Small Cell Lung Cancer and Coexisting Interstitial Lung Disease: A Systematic Review.
    Int J Radiat Oncol Biol Phys. 2017;98:622-631.
    PubMed     Text format     Abstract available


  30. WANG S, Campbell J, Stenmark MH, Zhao J, et al
    Plasma Levels of IL-8 and TGF-beta1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study.
    Int J Radiat Oncol Biol Phys. 2017;98:615-621.
    PubMed     Text format     Abstract available


  31. EZE C, Roengvoraphoj O, Manapov F
    Prophylactic Cranial Irradiation in Resected Early-Stage Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:612-614.
    PubMed     Text format    


  32. REDMOND KJ, Hales RK, Anderson-Keightly H, Zhou XC, et al
    Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation in Limited-Stage Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:603-611.
    PubMed     Text format     Abstract available


  33. PRESS RH, Boselli DM, Symanowski JT, Lankford SP, et al
    External Validity of a Risk Stratification Score Predicting Early Distant Brain Failure and Salvage Whole Brain Radiation Therapy After Stereotactic Radiosurgery for Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2017;98:632-638.
    PubMed     Text format     Abstract available


  34. RIEBER J, Abbassi-Senger N, Adebahr S, Andratschke N, et al
    Influence of Institutional Experience and Technological Advances on Outcome of Stereotactic Body Radiation Therapy for Oligometastatic Lung Disease.
    Int J Radiat Oncol Biol Phys. 2017;98:511-520.
    PubMed     Text format     Abstract available


    June 2017
  35. PAUL J, Yang C, Wu H, Tai A, et al
    Early Assessment of Treatment Responses During Radiation Therapy for Lung Cancer Using Quantitative Analysis of Daily Computed Tomography.
    Int J Radiat Oncol Biol Phys. 2017;98:463-472.
    PubMed     Text format     Abstract available


  36. HELOU J, Thibault I, Poon I, Chiang A, et al
    Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Histology, Dose, and Indication Matter.
    Int J Radiat Oncol Biol Phys. 2017;98:419-427.
    PubMed     Text format     Abstract available


  37. BASCH E, Pugh SL, Dueck AC, Mitchell SA, et al
    Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2017;98:409-418.
    PubMed     Text format     Abstract available


  38. BANG A, Wilhite TJ, Pike LRG, Cagney DN, et al
    Multicenter Evaluation of the Tolerability of Combined Treatment With PD-1 and CTLA-4 Immune Checkpoint Inhibitors and Palliative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;98:344-351.
    PubMed     Text format     Abstract available


    May 2017
  39. YAN SX, Qureshi MM, Truong MT, Mak KS, et al
    Patterns of Care and Survival Outcomes in Stage II Non-Small Cell Lung Cancer: An Analysis of the National Cancer Database.
    Int J Radiat Oncol Biol Phys. 2017;98:251.
    PubMed     Text format    


  40. DEVITT M, Hall R, Gentzler RD
    Peripheral Blood Cell Free DNA to Monitor Mutational Response in Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:250.
    PubMed     Text format    


  41. FAVE X, Zhang L, Yang J, Mackin D, et al
    Using Pretreatment Radiomics and Delta-Radiomics Features to Predict Non-Small Cell Lung Cancer Patient Outcomes.
    Int J Radiat Oncol Biol Phys. 2017;98:249.
    PubMed     Text format    


  42. LAN M, Xu T, Gomez DR, Jeter MD, et al
    Association Between LGALS3 Gene Polymorphisms and Survival in Non-Small Cell Lung Cancer Patients Treated With Definitive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;98:249-250.
    PubMed     Text format    


  43. GUTTMANN DM, Doucette A, Gabriel PE, Morrissette JJD, et al
    Patterns of Failure in Metastatic Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Implications for the Role of Definitive Local Therapy to the Primary Tumor.
    Int J Radiat Oncol Biol Phys. 2017;98:248-249.
    PubMed     Text format    


  44. AHERNE N, Tune D, Ross A, Dwyer P, et al
    Hippocampal Avoidance Prophylactic Cranial Irradiation in Small Cell Lung Carcinoma.
    Int J Radiat Oncol Biol Phys. 2017;98:248.
    PubMed     Text format    


  45. NI L, Koshy M, Connell PP, Hubert G, et al
    Impact of Cardiac Dose on Cardiac Events and Survival in Unresectable Lung Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2017;98:247.
    PubMed     Text format    


  46. SONI PD, Boonstra PS, Schipper M, Bazzi L, et al
    Lower Incidence of Esophagitis in the Elderly Undergoing Definitive Radiation Therapy for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:247-248.
    PubMed     Text format    


  47. CHEN H, Senan S, Nossent EJ, Boldt G, et al
    Treatment-Related Toxicity in Patients with Early Stage Non-Small Cell Lung Cancer and Co-Existing Interstitial Lung Disease: A Systematic Review.
    Int J Radiat Oncol Biol Phys. 2017;98:245-246.
    PubMed     Text format    


  48. XU T, Xu Y, Huo J, Yang P, et al
    Incidental Use of Beta-Blockers, Serum VEGF, and Their Association With Disease Outcome in Patients with Non-Small-Cell Lung Cancer Treated with Definitive Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;98:245.
    PubMed     Text format    


  49. ZENG H, Li R, Hu C, Meng X, et al
    Hyperfractionated Accelerated Radiation Therapy May Increase Risk for Brain Metastases in Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:244.
    PubMed     Text format    


  50. WEN Q, Meng X, Sun X, Hu M, et al
    Evaluation of Clinical and Demographic Factors Associated with Platinum-Sensitivity Status and Survival in Limited-Stage Small Cell Lung Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2017;98:243.
    PubMed     Text format    


  51. ROUNTREE CA, Zahra A, Russo JK, O'Keefe J, et al
    Once- (QD) Versus Twice-Daily (BID) Radiation Therapy (RT) Plus Concurrent Chemotherapy for Limited-Stage (LS) Small-Cell Lung Cancer (SCLC): A Comparative Outcomes Analysis.
    Int J Radiat Oncol Biol Phys. 2017;98:243-244.
    PubMed     Text format    


  52. ERKMEN C, Mitchell M
    Lung Cancer Screening in a Predominantly African-American Population.
    Int J Radiat Oncol Biol Phys. 2017;98:242-243.
    PubMed     Text format    


  53. SHIN J, Russo GA
    Survival is Increasing for Patients with Stage I Non-Small Cell Lung Cancer Treated With Primary Radiation Therapy: We are Making Progress in the Era of Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;98:241.
    PubMed     Text format    


  54. GOLDEN S, Thomas CR Jr, Slatore C
    It Wasn't as Bad as I Thought It Would Be: A Prospective, Qualitative Longitudinal Study of Early Stage Non-Small Cell Lung Cancer Patients After Treatment.
    Int J Radiat Oncol Biol Phys. 2017;98:241-242.
    PubMed     Text format    


  55. JIN CJ, Kong W, MacKillop W
    Estimating the Need for Palliative Radiation Therapy for Lung Cancer: A Benchmarking Approach.
    Int J Radiat Oncol Biol Phys. 2017;98:240-241.
    PubMed     Text format    


  56. DAVIS KL, Lenz C, Houghton K, Kaye JA, et al
    Real-World Clinical Outcomes of Crizotinib Treatment in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2017;98:239.
    PubMed     Text format    


  57. G L, Agarwal V, Swamy K, Bhattacharjee S, et al
    Stereotactic Robotic Radiosurgery for 1-3 Brain Metastases from Non-Small Cell Lung Cancer: A Single Institutional Experience from South India.
    Int J Radiat Oncol Biol Phys. 2017;98:238.
    PubMed     Text format    


  58. DAVIS KL, Lenz C, Houghton K, Kaye JA, et al
    Clinical Outcomes of Crizotinib in Real-World Practice Settings for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:238-239.
    PubMed     Text format    


  59. NGUYEN QN, Lu Y, Tang C, Chance WW, et al
    Stereotactic Ablative Body Radiation for Pulmonary Metastases: Should We Consider Dose Escalation for More Unresponsive Histologies?
    Int J Radiat Oncol Biol Phys. 2017;98:237.
    PubMed     Text format    


  60. MO X
    Low Expression of 12 DNA Repair Genes was Associated With Better Disease-free Survival in Non-Small Cell Lung Cancer Patients Having Adjuvant Chemotherapy.
    Int J Radiat Oncol Biol Phys. 2017;98:237.
    PubMed     Text format    


  61. YANG F, Chen L, Cheung W
    Attrition in the Treatment of Metastatic Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:237.
    PubMed     Text format    


  62. HORNE ZD, Richman A, Clump DA 2nd, Burton SA, et al
    Mediastinal/Hilar Stereotactic Ablative Radiation Therapy for Primary and Oligorecurrent Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:237-238.
    PubMed     Text format    


  63. GENTZLER RD, Mohindra NA, Hanna N, Chae YK, et al
    Carboplatin/nab-Paclitaxel and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): Phase 1 Results.
    Int J Radiat Oncol Biol Phys. 2017;98:236.
    PubMed     Text format    


  64. WEN Q, Meng X, Yue J, Ma C, et al
    Prediction of Early Response to Chemoradiation Therapy in Non-Small Cell Lung Cancer by Using Cone Beam Computed Tomography-Based Tumor Volume and Density Changes.
    Int J Radiat Oncol Biol Phys. 2017;98:235.
    PubMed     Text format    


  65. ALJUMAILY R, Pleat N, George S, John S, et al
    A Histologic Guide in Treating Stage III Non-Small Cell Lung Cancer: A Single Institution Retrospective Analysis.
    Int J Radiat Oncol Biol Phys. 2017;98:235.
    PubMed     Text format    


  66. ACKERSON B, Boyle JM, Gu L, Kelsey CR, et al
    A Formal Assessment of the Dosimetric Advantages of Intensity-Modulated Radiation Therapy in Locally Advanced Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:234.
    PubMed     Text format    


  67. YANG P, Liao Z, Gomez DR, Xu T, et al
    Prospective Study of Marginal Recurrence in Patients with Non-Small Cell Lung Cancer After Proton or Photon Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;98:234.
    PubMed     Text format    


  68. LIU J, Li C, Hu M, Lu J, et al
    Exploring Spatial Overlap of High-Uptake Regions Derived From Dual Tracer PET/CT Imaging Using 18F-FDG and 18F-FLT in Non-Small Cell Lung Cancer Patients: A Prospective Pilot Study.
    Int J Radiat Oncol Biol Phys. 2017;98:233.
    PubMed     Text format    


  69. TAKEHANA K, Inokuchi H, Tsutsui K, Hiraoka M, et al
    Comparison of Radiation Dose of Induction Chemoradiation Therapy Followed by Surgery for Potentially Resectable Stage III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:233-234.
    PubMed     Text format    


  70. NO H, Kikut J, Garrison G, Sidiropoulos N, et al
    Active Surveillance for Elderly Stage IA Non-Small Cell Lung Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2017;98:232.
    PubMed     Text format    


  71. SINGH DP, Bergsma DP, Cummings MA, Hare MZ, et al
    Outcome with Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer Using 5 Fractions: Single Institution Experience of 106 Consecutive Patients.
    Int J Radiat Oncol Biol Phys. 2017;98:231-232.
    PubMed     Text format    


  72. MANSUETI JR, Maillie S
    A Review of Non-Small Cell Lung Cancer Post-Treatment Follow-up Imaging Procedures with PET/CT Scans Versus CT Scans and the Effect on Patient Survival.
    Int J Radiat Oncol Biol Phys. 2017;98:231.
    PubMed     Text format    


  73. POST CM, Verma V, Zhen W, Simone CB 2nd, et al
    Stereotactic Body Radiation Therapy for >/=5 cm Non-Small Cell Lung Cancer: Survey of United States Academic Thoracic Radiation Oncologists.
    Int J Radiat Oncol Biol Phys. 2017;98:230-231.
    PubMed     Text format    


  74. BLUMENFELD PA, Kreinbrink PJ, Marwaha G
    Stereotactic Body Radiation Therapy Outcomes for Early Stage and Oligometastatic Non-Small Cell Lung Cancer Based on Molecular Profile.
    Int J Radiat Oncol Biol Phys. 2017;98:230.
    PubMed     Text format    


  75. PEZZI TA, Mohamed ASR, Fuller CD, Blanchard P, et al
    Radiation Therapy is Independently Associated With Worse Survival After R0 Resection for Stage I-II Non-Small Cell Lung cancer: An Analysis of the National Cancer Data Base.
    Int J Radiat Oncol Biol Phys. 2017;98:230.
    PubMed     Text format    


  76. CASSIDY RJ 3RD, Patel PR, Zhang X, Press RH, et al
    Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer in Patients 80 Years and Older: A Multi-Center Analysis.
    Int J Radiat Oncol Biol Phys. 2017;98:229-230.
    PubMed     Text format    


  77. QIN A, Street L, Viglianti BL, Cease K, et al
    Clinical Predictors of Durable Clinical Benefit of Pembrolizumab Therapy in Veterans With Metastatic Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:228.
    PubMed     Text format    


  78. NAGASAKA M, Sukari A
    Non-Small Cell Lung Cancer: Does Histology Matter?
    Int J Radiat Oncol Biol Phys. 2017;98:227-228.
    PubMed     Text format    


  79. GAO Z, Meng X, Chen X, Sun X, et al
    Comparison of Tumor Volumes as Determined by Pathologic Examination and FLT-PET/CT Images of Non-Small Cell Lung Cancer: A Pilot Study.
    Int J Radiat Oncol Biol Phys. 2017;98:226-227.
    PubMed     Text format    


  80. RAY M, Faris N, Rugless F, Smeltzer M, et al
    Multidisciplinary Care and the Use of Treatment Modalities for Non-Small Cell Lung Cancer (NSCLC) in a Large Community Healthcare Setting.
    Int J Radiat Oncol Biol Phys. 2017;98:226.
    PubMed     Text format    


  81. ZHU HJ, Nichols RC Jr, Henderson RH, Morris CG, et al
    Impact of Unfavorable Factors on Outcomes Among Inoperable Stage II-IV Non-Small Cell Lung Cancer Patients Treated with Proton Therapy.
    Int J Radiat Oncol Biol Phys. 2017;98:225.
    PubMed     Text format    


  82. GEBHARDT BJ, Horne ZD, Heron DE, Beriwal S, et al
    Standardization of Radiation Therapy Dose for Locally Advanced Non-Small Cell Lung Cancer Through Changes to a Lung Cancer Clinical Pathway in a Large, Integrated Comprehensive CancerCenter Network.
    Int J Radiat Oncol Biol Phys. 2017;98:225.
    PubMed     Text format    


  83. SHARMA S, McMillan M, Doucette A, Cohen R, et al
    Impact of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small Cell Lung Cancer: A Propensity Score Matched Analysis of Patients in the National Cancer Database.
    Int J Radiat Oncol Biol Phys. 2017;98:224-225.
    PubMed     Text format    


  84. AHMED KA, Grass GD, Creelan B, Gray J, et al
    Tolerability and Safety of Thoracic Radiation and Immune Checkpoint Inhibitors Among Patients with Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:224.
    PubMed     Text format    


  85. GAO S, Kim A, Puchalski J, Bramley K, et al
    Indications for Invasive Mediastinal Staging in Patients with Early Non-Small Cell Lung Cancer Staged with Positron Emission Tomography-Computed Tomography.
    Int J Radiat Oncol Biol Phys. 2017;98:223.
    PubMed     Text format    


  86. SEPESI B, Cuentes EP, Canales JR, Behrens C, et al
    Tumor-Infiltrating Lymphocytes and Overall Survival in Surgically Resected Stage II and III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:223.
    PubMed     Text format    


  87. DALWADI SM, Lewis G, Butler EB, Teh BS, et al
    Racial Disparities in the Treatment and Outcome of Stage I Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:223-224.
    PubMed     Text format    


  88. JOLLY S, Sun Y, Hawkins PG, Bi N, et al
    Individualizing Radiation Dose in Locally Advanced Non-Small Cell Lung Cancer Patients Using Pretreatment Serum MicroRNA Signatures.
    Int J Radiat Oncol Biol Phys. 2017;98:222.
    PubMed     Text format    


  89. CHINNIAH C, Aguarin L, Cheng P, DeCesaris C, et al
    Prospective Trial of Circulating Tumor Cells as a Biomarker for Early Detection of Recurrence in Patients with Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;98:221.
    PubMed     Text format    


  90. SINGH AK, Suescun JAG, Stephans KL, Bogart JA, et al
    A Phase 2 Randomized Study of 2 Stereotactic Body Radiation Therapy Regimens for Medically Inoperable Patients With Node-Negative, Peripheral Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;98:221-222.
    PubMed     Text format    


  91. EDELMAN MJ, Wang X, Hodgson L, Cheney RT, et al
    Final Results of a Phase 3 Trial of Celecoxib (C) in Addition to Standard Chemotherapy for Advanced Non-Small Cell Lung Cancer With COX- 2 Overexpression: CALGB 30801 (Alliance).
    Int J Radiat Oncol Biol Phys. 2017;98:220-221.
    PubMed     Text format    


  92. PIOTROWSKA Z, Stirling K, Heist R, Campo M, et al
    Heterogeneity and Variation in Resistance Mechanisms Among 223 Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Patients With > 1 Post-Resistance Biopsy.
    Int J Radiat Oncol Biol Phys. 2017;98:220.
    PubMed     Text format    


  93. FARRIS M, McTyre ER, Cramer CK, Hughes R, et al
    Brain Metastasis Velocity: A Novel Prognostic Metric Predictive of Overall Survival and Freedom From Whole-Brain Radiation Therapy After Distant Brain Failure Following Upfront Radiosurgery Alone.
    Int J Radiat Oncol Biol Phys. 2017;98:131-141.
    PubMed     Text format     Abstract available


  94. WANG CJ, Christie A, Lin MH, Jung M, et al
    Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
    Int J Radiat Oncol Biol Phys. 2017;98:91-100.
    PubMed     Text format     Abstract available


    March 2017
  95. FOGH SE, Deshmukh S, Berk LB, Dueck AC, et al
    A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012.
    Int J Radiat Oncol Biol Phys. 2017;97:786-796.
    PubMed     Text format     Abstract available


  96. VERMA V, Shostrom VK, Zhen W, Zhang M, et al
    Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (>/=5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis.
    Int J Radiat Oncol Biol Phys. 2017;97:778-785.
    PubMed     Text format     Abstract available


    February 2017
  97. OHRI N, Bodner WR, Halmos B, Cheng H, et al
    18F-Fluorodeoxyglucose/Positron Emission Tomography Predicts Patterns of Failure After Definitive Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:372-380.
    PubMed     Text format     Abstract available


  98. MISHRA MV, Aggarwal S, Bentzen SM, Knight N, et al
    Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials.
    Int J Radiat Oncol Biol Phys. 2017;97:228-235.
    PubMed     Text format     Abstract available


    January 2017
  99. GIULIANI M, Hope A, Guckenberger M, Mantel F, et al
    Stereotactic Body Radiation Therapy in Octo- and Nonagenarians for the Treatment of Early-Stage Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017 Jan 9. pii: S0360-3016(17)30023.
    PubMed     Text format     Abstract available



  100. Erratum to Guo W, Du S, Yang L, et al. Stat3 activation mediates stem cell, DNA repair, and immunosuppressive properties in crizotinib-resistance EML4-ALK-rearranged lung cancer. Int J Radiat Oncol Biol Phys 2016;96:S76-S77.
    Int J Radiat Oncol Biol Phys. 2017;97:210.
    PubMed     Text format    


  101. HIGGINS KA, O'Connell K, Liu Y, Gillespie TW, et al
    National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2017;97:128-137.
    PubMed     Text format     Abstract available


  102. KANEHIRA T, Matsuura T, Takao S, Matsuzaki Y, et al
    Impact of Real-Time Image Gating on Spot Scanning Proton Therapy for Lung Tumors: A Simulation Study.
    Int J Radiat Oncol Biol Phys. 2017;97:173-181.
    PubMed     Text format     Abstract available


  103. LEEMAN JE, Rimner A, Montecalvo J, Hsu M, et al
    Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2017;97:138-145.
    PubMed     Text format     Abstract available


    December 2016
  104. BROOKS ED, Sun B, Zhao L, Komaki R, et al
    Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Dec 21. pii: S0360-3016(16)33596.
    PubMed     Text format     Abstract available


  105. VANDERWALDE NA, Deal AM, Comitz E, Stravers L, et al
    Geriatric Assessment as a Predictor of Tolerance, Quality of Life, and Outcomes in Older Patients With Head and Neck Cancers and Lung Cancers Receiving Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016 Dec 2. pii: S0360-3016(16)33507.
    PubMed     Text format     Abstract available


  106. VIDETIC GM
    Early-Stage Lung Cancer, Surgery, and Stereotactic Body Radiation Therapy: Quality of Life.
    Int J Radiat Oncol Biol Phys. 2016;96:927-930.
    PubMed     Text format    


  107. IRIE D, Saitoh JI, Shirai K, Abe T, et al
    Verification of Dose Distribution in Carbon Ion Radiation Therapy for Stage I Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96:1117-1123.
    PubMed     Text format     Abstract available


  108. STAHL JM, Ross R, Harder EM, Mancini BR, et al
    The Effect of Biologically Effective Dose and Radiation Treatment Schedule on Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96:1011-1020.
    PubMed     Text format     Abstract available


    November 2016
  109. BRADLEY J, Hu C
    Learning From Trials on Radiation Dose in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96:748-750.
    PubMed     Text format     Abstract available


  110. RAMROTH J, Cutter DJ, Darby SC, Higgins GS, et al
    Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials.
    Int J Radiat Oncol Biol Phys. 2016;96:736-747.
    PubMed     Text format     Abstract available


  111. VERMA V, Simone CB 2nd, Allen PK, Gajjar SR, et al
    Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Nov 2. pii: S0360-3016(16)33392.
    PubMed     Text format     Abstract available


  112. INOUE T, Widder J, van Dijk LV, Takegawa H, et al
    Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96:661-9.
    PubMed     Text format     Abstract available


  113. DU S, Lockamy V, Zhou L, Xue C, et al
    Stereotactic Body Radiation Therapy Delivery in a Genetically Engineered Mouse Model of Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96:529-37.
    PubMed     Text format     Abstract available


    October 2016
  114. BOYER MJ, Williams C, Kelley MJ, Salama JK, et al
    Survival With Stereotactic Body Radiation Therapy (SBRT) and Conventional Radiation Therapy (CRT) in Stage I Non-Small Cell Lung Cancer Patients in the Veterans Affairs System.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  115. VIDETIC GM, Gomez Suescun JA, Stephans KL, Bogart JA, et al
    A Phase 2 Randomized Study of 2 Stereotactic Body Radiation Therapy (SBRT) Regimens for Medically Inoperable Patients With Node-Negative, Peripheral Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  116. BEZJAK A, Paulus R, Gaspar LE, Timmerman RD, et al
    Efficacy and Toxicity Analysis of NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  117. QIU M, Wu Z, Yuan Z, Meng M, et al
    MIR384, Inhibited By NF-Kb, Enhances Radiosensitivity in Human Non-Small Cell Lung Cancer Via Modulating DNA Damage Response and Repair Signaling.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  118. GUO W, Du S, Yang L, Dicker AP, et al
    Stat3 Activation Mediates Stem Cell, DNA Repair, and Immunosuppressive Properties in Crizotinib-Resistance ELM4-ALK-Rearranged Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  119. LOK BH, Feng Y, Gardner EE, Yu GK, et al
    SLFN11 Is Necessary for Single Agent Sensitivity to Talazoparib, a Potent PARP Inhibitor, But Not for Radiosensitization in Small Cell Lung Cancer (SCLC) Cell Lines and Patient-Derived Xenografts (PDX).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  120. FENG W, Fu XL, Cai XW, Zhang Q, et al
    The Differential Impact of Postoperative Radiation Therapy for Completely Resected Stage IIIA (N2) Non-Small Cell Lung Cancer: Based on the Risk Prediction Model for Locoregional Recurrence.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  121. HERSKOVIC A, Christos P, Mauer E, Nagar H, et al
    The Role of Postoperative Radiation Therapy in pN2 Non-Small Cell Lung Cancer: An Analysis of the National Cancer Data Base.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  122. GAO S, Corso CD, Detterbeck FC, Boffa D, et al
    Effects of Adjuvant Therapy on Survival in T3N0 Non-Small Cell Lung Cancer Invading the Chest Wall.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  123. DALWADI SM, Szeja S, Teh BS, Butler EB, et al
    Outcomes in Elderly Stage I Non-Small Cell Lung Cancer in the Stereotactic Body Radiation Therapy Era: A Surveillance, Epidemiology, and End Results Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  124. MAGNUSON WJ, Amini A, Patil T, Kavanagh BD, et al
    Deferring Radiation Therapy for Brain Metastases in Patients With EGFR-Mutant Non-Small Cell Lung Cancer: A Multi-Institutional Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  125. REDMOND KJ, Hales RK, Zhou XC, Kummerlowe M, et al
    A Prospective Study of Hippocampal-Sparing Prophylactic Cranial Irradiation (PCI) in Limited-Stage Small Cell Lung Cancer (SCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  126. MATTONEN SA, Palma DA, Johnson C, Louie AV, et al
    Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy (SABR) for Lung Cancer: Physician Performance Versus Radiomic Assessment.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  127. MCWILLIAM A, Faivre-Finn C, Kennedy J, Kershaw L, et al
    Data Mining Identifies the Base of the Heart as a Dose-Sensitive Region Affecting Survival in Lung Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  128. JACKSON MW, Schubert LK, Jones B, Castillo R, et al
    A Novel Lung Function Imaging Modality for Surgical Lung Cancer Evaluation.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  129. TANG C, Amer A, Hobbs B, Li X, et al
    Pathology-Based Non-Small Cell Lung Cancer Radiomics Signature Describing the Local Tumor Immune Environment: Discovery and Validation.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  130. CHAUDHURI AA, Lovejoy AF, Chabon JJ, Newman A, et al
    CAPP-Seq Circulating Tumor DNA Analysis for Early Detection of Tumor Progression After Definitive Radiation Therapy for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  131. HOLMES JA, Chen RC
    Racial Disparities in Time From Diagnosis to Treatment for Stage IA Non-Small Cell Lung Cancer (NSCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  132. MANNING M, Cykert S, Eng E, Yee MK, et al
    Reducing Racial Disparities in Treatment for Early-Stage Lung Cancer With a Multimodal Intervention.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  133. SAPIR E, Tao Y, Lin J, Kollar L, et al
    Surgical Resection or Stereotactic Body Radiation Therapy for Sarcoma Patients With Pulmonary Metastases.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  134. ALLEN BG, Schoenfeld JD, Sibenaller ZA, Mapuskar KA, et al
    Pharmacological Ascorbate Enhances the Response of Non-Small Cell Lung Cancer (NSCLC) to Radiation and Chemotherapy Via Disruptions of Redox Active Iron Leading to Increased H2O2.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  135. YAMAMOTO T, Kabus S, Bal M, Keall P, et al
    Computed Tomography Ventilation Image Guided Adaptive Functional Avoidance in Radiation Therapy for Locally Advanced Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  136. KANG M, Huang S, Solberg TD, Mayer R, et al
    A Study of the Beam-Specific Interplay Effect in Proton Pencil Beam Scanning Delivery in Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  137. DHOU S, Ionascu D, Cai W, Hurwitz M, et al
    Interfraction Variability of Motion Models Derived Using Patient 4-Dimensional Cone Beam Computed Tomography Images for Lung Cancer Stereotactic Body Radiation Therapy (SBRT) Patients.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  138. AKTHAR AS, Koshy M, Ferguson MK, Murgu S, et al
    Does Endoscopic Bronchial Ultrasound (EBUS) Impact Outcomes in Stage I Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Hypofractionated Radiation Therapy (HFRT)?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  139. AHMED KA, Creelan BC, Kim S, Dilling TJ, et al
    Safety and Tolerability of Extracranial Radiation Therapy and Immune Checkpoint Inhibitors Among Patients With Metastatic Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  140. GRENDAROVA P, Arora R, Bebb GD, D'Silva A, et al
    Sarcopenia Is Associated With Worse Overall Survival in Patients With Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  141. ZAKI M, Xu Y, Dominello MM, Dyson G, et al
    Radiation Dose to the Heart and Mortality in Patients Receiving Definitive Chemoradiation Therapy for Stage III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  142. PALY J, Shaikh T, Scott WJ, Flieder D, et al
    Comparative Effectiveness of Standard Versus High-Dose Neoadjuvant Chemoradiation Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  143. LAN M, Xu T, Yue J, Yang J, et al
    Polymorphisms of BMP4 and HIF-1A Are Associated With Patient-Reported Symptoms in Non-Small-Cell Lung Cancer Patients Treated With Definitive Chemoradiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  144. VOGEL J, Wang X, Troxel A, Simone CB 2nd, et al
    Prospective Assessment of Demographic Characteristics Associated With Worse Health-Related Quality of Life Measures Following Definitive Chemoradiation in Patients With Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  145. BROWER JV, Amini A, Hullett CR, Wojcieszynski AP, et al
    Dose-Escalated Radiation Therapy Is Associated With Improved Survival in Patients With Stage III Non-Small Cell Lung Cancer: Analysis of the National Cancer Data Base.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  146. KIM H, Ahn YC, Pyo HR, Oh D, et al
    Are New ypN Stages Predictive of Survival in 477 Lung Cancer Patients Who Underwent Trimodality Therapy for Initial pN2 Disease?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  147. ZHANG H, Yan L, Huang K, Campbell J, et al
    Normalized Median Geodesic Distance, a Novel Shape Descriptor, Predicts Survival in Non-Small Cell Lung Cancer After Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  148. VAN TIMMEREN JE, Leijenaar RT, van Elmpt W, Lambin P, et al
    Interchangeability of a Radiomic Signature Between Conventional and Weekly Cone Beam Computed Tomography Allowing Response Prediction in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  149. PAUL J, Gore EM, Li A
    Quantitative Computed Tomography for Tumor Response Assessment During Radiation Therapy for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  150. DE JONG E, van Elmpt W, Leijenaar RT, Carvalho S, et al
    Prospective Validation of a Prognostic Computed Tomography-Based Radiomic Signature in Stage IV Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  151. DING X, Qian D, Cheng J, Yuan Z, et al
    In Vitro and In Vivo Radiosensitization by Telomerase Inhibitor BRBR1532 in Human Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  152. LOCKNEY NA, Pei X, Blumberg LE, Chan TA, et al
    PIK3CA Activating Mutations Are Associated With Decreased Local Control in Lung Cancer Brain Metastases Treated With Radiation.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  153. HOLMES JA, Chen RC
    Adoption of Stereotactic Body Radiation Therapy (SBRT) for Stage IA Non-Small Cell Lung Cancer (NSCLC) Across the United States and Patterns of Dose Prescriptions.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  154. STAHL JM, Ross R, Harder EM, Mancini BR, et al
    A Biologically Effective Dose of >/=105 Gy Is Associated With Improved Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  155. JAIN S, Amini A, Rusthoven CG
    High-Dose Thoracic Radiation Therapy Is Associated With Improved Survival in Metastatic Non-Small Cell Lung Cancer (NSCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  156. VALDES G, Berman AT, Hann-Hsiang C, Solberg TD, et al
    Machine Learning Analysis Can Identify Clinical and Dosimetric Factors Predictive of Chest Wall Syndrome in Patients With Stage I Non-Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  157. CHAO HH, Berman AT, Mick R, Ciunci C, et al
    Central Volume Target Overlap and Esophageal Dose Predict for Toxicity in a Prospective Study of Reirradiation for Non-Small Cell Lung Carcinoma Using Proton Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  158. LAMMERS A, Golden S, Thomas CR Jr, Mitin T, et al
    Lung Cancer Specialists' Opinions on Treatments for Stage I Lung Cancer: A Multidisciplinary Survey.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  159. CHEN B, Zhou L, He J, Xiong W, et al
    Neurocognitive Function and Quality of Life in EGFR-Mutated Non-Small Cell Lung Cancer Patients With Brain Metastases Treated With Icotinib and Whole-Brain Radiation: Results of a Phase 1 Trial.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  160. OFORI M, Sekhar K, Crooks P, Penthala N, et al
    Targeting NPM1 for the Radiosensitization of Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  161. MAK RH, Hermann G, Aerts H, Chen AB, et al
    Outcomes by EGFR, KRAS and ALK Genotype After Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  162. YANG J, Xu T, Yuan X, Gomez DR, et al
    Single Nucleotide Polymorphisms in BMP/Smad4/Hamp Are Associated With Outcome of Patients Receiving Definitive Radiation Therapy for Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  163. WALIANY S, Shultz DB, Gensheimer MF, Loo BW Jr, et al
    Role of Surveillance Imaging Versus Symptoms and Signs in Detection of Recurrence of Non-Small Cell Lung Cancer After Curative Intent Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  164. KUMAR S, Li X, Feddock J, McGarry RC, et al
    An Update on Results Regarding a Prospective Study of SBRT for Post-chemoradiation Residual Disease in Stage II/III Non-small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  165. ZHANG Q, Fu X
    Safety of Dose Escalation by Simultaneous Integrated Boosting Radiation Dose in Unresectable Stage III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  166. LIANG J
    Combination Therapy With Celecoxib and Concurrent Chemoradiation Therapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer: Primary Analysis of a Randomized Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  167. SLOTMAN BJ, Faivre-Finn C, van Tinteren H, Keijser A, et al
    Identifying Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC) Most Likely to Benefit From Intensive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  168. SENTER J, Hooker C, Lang M, Voong KR, et al
    Thoracic Multidisciplinary Clinic Improves Survival in Patients With Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  169. LI Y, Liang S, Zhou Z, Cai Y, et al
    Risk Factor Study of Radiation Pneumonitis Focused on Subclinical Interstitial Lung Disease in Definitive Radiation Therapy for Non-Small Cell Lung Cancer: A Single-Institution Experience.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  170. DENG L, Zhang J, Liu Y, Sun X, et al
    Failure Pattern of Oligometastatic EGFR-Mutant Non-Small Cell Lung Cancer Treated With Tyrosine Kinase Inhibitors: Implication of Upfront Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  171. TSUJINO K, Kubota H, Kawaguchi H, Matsumoto Y, et al
    Risk Factors Associated With Fatal Radiation Pneumonitis after Concurrent Chemoradiation Therapy for Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  172. WANG K, Eblan MJ, Zagar TM, Lee CB, et al
    Cardiac Toxicity After Radiation for Stage III Non-Small Cell Lung Cancer: Pooled Analysis of Several Prospective Dose-Escalation Trials Delivering 70 to 90 Gy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  173. BARNEY C, Scoville N, Haglund KE, Grecula JC, et al
    Radiation Dose to the Thoracic Vertebral Bodies Is Associated With Acute Hematologic Toxicity in Patients Receiving Concurrent Chemoradiation for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  174. GORE EM, Hu C, Ad VB, Robinson CG, et al
    Impact of Incidental Cardiac Radiation on Cardiopulmonary Toxicity and Survival for Locally Advanced Non-Small Cell Lung Cancer: Reanalysis of NRG Oncology/RTOG 0617 With Centrally Contoured Cardiac Structures.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  175. BISSONNETTE JP, Bezjak A, Becker N, Vines D, et al
    Serial 4-Dimensional (4D) Computed Tomography/4D Positron Emission Tomography Imaging to Predict and Monitor Response for Locally Advanced Non-Small Cell Lung Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  176. POKHREL D, Sood SS, Shen X, McClinton CM, et al
    Modeling of Tumor Control Probability and Rib Toxicity for Peripherally Located Non-Small Cell Lung Cancer (NSCLC) Lesions Treated With Monte Carlo-Based Dose Algorithm.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  177. KIMURA T, Nakashima T, Saito A, Takeuchi Y, et al
    Combined Ventilation and Perfusion Imaging Correlates With the Dosimetric Parameters of Radiation Pneumonitis in Radiation Therapy Planning for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  178. GAO S, Kim AW, Detterbeck FC, Boffa D, et al
    Indications for Invasive Mediastinal Staging in Patients With Early Non-Small Cell Lung Cancer Staged With Positron Emission Tomography/Computed Tomography.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  179. WU J, Gensheimer MF, Dong X, Rubin DL, et al
    Intratumor Partitioning of Serial Computed Tomography and FDG Positron Emission Tomography Images Identifies High-Risk Tumor Subregions and Predicts Patterns of Failure in Non-Small Cell Lung Cancer After Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  180. SHIOYAMA Y, Yamamoto N, Saitoh JI, Fujii O, et al
    Multi-institutional Retrospective Study of Carbon Ion Radiation Therapy for Stage I Non-Small Cell Lung Cancer: Japan Carbon Ion Radiation Oncology Study Group.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  181. LOUIE AV, Chen H, Van Werkhoven E, Smit E, et al
    Quality of Life Following Stereotactic Ablative Radiation Therapy Versus Surgery for Early-Stage Lung Cancer: Results From the ROSEL Randomized Controlled Trial and a Systematic Review.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  182. OLSON AC, Patel K, Mowery YM, Wynne J, et al
    Anti-PD-1 Therapy and Stereotactic Radiation for Melanoma and Non-Small Cell Lung Cancer Patients with Brain Metastases: A 2-Institution Series.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  183. CHUNG SY, Chang JH, Lee CG, Suh CO, et al
    Optimal Dose and Volume for Postoperative Radiation Therapy in Patients With 1 to 4 Brain Metastases From Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  184. MUCCIGROSSO DJ, Maughan NM, Wan H, Lu Y, et al
    The Relationship Between Implantation Distance and Fraction Number With Fiducial Accuracy During Lung Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  185. O'CONNELL D, Shaverdian N, Kishan AU, Thomas DH, et al
    Clinical Validation and Implementation of the 5DCT Technique for Breathing-Gated Image Generation for Lung Cancer Treatment Planning.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  186. ZHOU M, Zou L, Chen QQ, Tian Y, et al
    The Assessment of Cognitive Function in Lung Cancer Patients With Brain Metastases Before and After Whole-Brain Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  187. ZHANG H, Jin JY, Wang W, Campbell J, et al
    A Prognostic Model Combining Genetic Variations in the Transforming Growth Factor-Beta1 Pathway and Clinical Factors for Non-Small Cell Lung Cancer After Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  188. KATZ LM, Shin S, McCarthy A, Schiff PB, et al
    The Use of Stereotactic Body Radiation Therapy Treatment for Lung Cancer in the Primary and Salvage Settings: Defining a New Clinical Niche.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  189. LIU M, Ge C, Liu B, Zhang Y, et al
    A Dosimetric Comparative Study of Rapid-ARC and Rapid-ARCFFF for Primary Lung Cancer or Lung Metastases With Hypofractionated Radiation Therapy of Small Target Volume.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  190. MA CM, Eldib A, Chibani O, Mora G, et al
    Exploring the Dosimetric Advantages of Cobalt Beams for Lung Cancer Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  191. KU E, Desai AY, Fang D, Lawrence C, et al
    Toxicity Profile in Non-Small Cell Lung Cancer Patients Treated With Lung Stereotactic Body Radiation Therapy Using the Modified Dynamic Conformal Arc (MDCA) Technique.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  192. SAKATA Y, Hirai R, Taguchi Y, Mori S, et al
    Marker-less Tumor Tracking for Lung Cancer by Tumor Image Pattern Learning.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  193. IMANO N, Nishibuchi I, Kimura T, Nakashima T, et al
    Impact of Expiratory Tumor Motion Patterns on Dose-Volume Histogram in Treatment Phase Selection of Respiratory Gating Radiation Therapy for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  194. CHALUBINSKA-FENDLER J, Karolczak L, Fendler W, Bury J, et al
    Feasibility of Texture Analysis-Based Dosimetry in Computed Tomography Scans During Radiation Therapy of Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  195. IRAMINA H, Nakamura M, Iizuka Y, Mitsuyoshi T, et al
    Accuracy of Target Motion Trajectory in 4-Dimensional Cone Beam Computed Tomography for Lung Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  196. HASHIMOTO M, Ito Y, Takahashi R, Nakajima M, et al
    Four-Dimensional Dose Reconstruction for Lung Cancer in Volumetric Modulated Arc Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  197. GRINCHAK TA, Sokolovic C, Holland B, Parent T, et al
    Response Criteria in Solid Tumors (PERCIST/RECIST) and SUVmax in Early-Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  198. DIAMANT AA, Seuntjens J, El Naqa I, Al-Halabi H, et al
    Prediction of Distant Metastasis Using Dose-Volume Metrics in Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  199. MAHMOOD J, Murti SC, Zaveri SR, Shukla HD, et al
    Caveolin-1: A Novel Prognostic Biomarker for Radioresistance in Non-Small Cell Lung Carcinoma (NSCLC) and Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  200. COROLLER TP, Agrawal V, Narayan V, Grossmann P, et al
    Radiomics Predict Pathological Response in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  201. HUYNH E, Coroller TP, Narayan V, Agrawal V, et al
    Radiomics Analysis of Stereotactic Body Radiation Therapy Patients With Lung Cancer Predicts Recurrent Disease.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  202. QIAN D, Cheng J, Ding X, Yuan Z, et al
    Phosphoglycerate Mutase 5-Mediated Mitochondrial Apoptosis/Necrosis Pathways and Mitophagy Determine the Mode of Cell Death Induced by Ionizing Radiation in Non-Small-Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  203. YANG D, O'Leary C, Deraska PV, D'Andrea AD, et al
    Exploiting Homologous Recombination Defects in N on-Small Cell Lung Cancer Through Combined PARP and Wee1 Inhibition.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  204. ZHANG H, Wan C, Yang C, Qin Y, et al
    Stereotactic Body Radiation Therapy Gains Radiobiological Advantages Not in Non-Small Cell Lung Cancer Cells After Radiation But in Early Passage Cells Compared to Conventional Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  205. TAI A, Liu F, Li A
    Modeling Tumor Regrowth After Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  206. KARANAM NK, Srinivasan K, Sishc B, Ding LH, et al
    Tumor Treatment Fields Can Enhance the Radio- and Chemosensitivity of Non-Small Cell Lung Cancer Cell Lines.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  207. SERRANO N, Alam A, Rabender C, Weiss E, et al
    Analysis of Circulating Tumor Exosomes: Their Role in the Tissue Microenvironment and Ability to Serve as a Biomarker for Recurrence in Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  208. MUNSHI A, Griffith J, Jin H, Algan O, et al
    Biological Effects of Proton and Photon Radiation in Non-Small Cell Lung Cancer Cell Lines.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  209. PATEL C, Attia A, Shinohara ET, Perkins SM, et al
    Post-treatment Cardiac Mortality in Non-Small Cell Lung Cancer Patients in the Modern Era.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  210. PATEL C, Attia A, Shinohara ET, Perkins SM, et al
    Immediate 90-Day Stress-Related Cardiovascular Mortality: The Shock of Lung Cancer Diagnosis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  211. YANG K, Miller JA, Balagamwala EH, Angelov L, et al
    Spine Stereotactic Body Radiation Therapy for Palliative Management of Metastatic Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  212. GIAP F, Lau SK, Gannavaparu BS, Iyengar P, et al
    Impact of Baseline Cachexia in Non-Small Cell Lung Cancer on Radiation Therapy Utilization and Survival.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  213. CHOONG ES, Yang J, Kennedy C, Tse RV, et al
    Pathological Stage IIIA, pN2 Non-Small Cell Lung Cancer (NSCLC) With Staging 18-FDG Positron Emission Tomography (PET): Is There a Role for Adjuvant Radiation Therapy (ART)?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  214. KONG FM, Campbell J, Jin JY, Jolly S, et al
    Risk Factors for Noncancer Progression-Associated Death in Patients With Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  215. KANG KH, Sharma N, Effird JT, Yang M, et al
    Pretreatment Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios and Lymphocyte Nadir as Predictors for Outcome in Stage III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  216. ANDERSON E, Filippi AR, Badellino S, Ricardi U, et al
    Imaging Features Associated With Disease Progression After Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Multi-Institutional Pooled Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  217. DAJAC J, Bhattal G, Keller A, Pavlovic Z, et al
    Evaluation of Overall Survival Following Stereotactic Radiosurgery (SRS) for Non-Small Cell Lung Cancer Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  218. SOIKE M, Farris M, Russell G, Feehs K, et al
    Are Individual Chemotherapy Agents Given with Radiation Related to Improved Outcomes in Patients with Stage IIB-IIIB Non-Small Cell Lung Cancer?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  219. WILD AT, Jackson A, Kohutek ZA, Wu AJ, et al
    Planning Target Volume and FDG-PET Maximum Standardized Uptake Value, But Not Dosimetric Parameters of Target Coverage, Predict for Local Recurrence After Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  220. TJONG MC, Faruqi S, Helou J, Zhang L, et al
    Post-Stereotactic Body Radiation Therapy (SBRT) Tumor Response and Inflammatory Changes as Predictors of Nonlocal Failure and Survival Outcomes in Patients With Stage I Non-Small Cell Lung Cancer (NSCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  221. LEE A, Ohri N, Purswani J, Yaparpalvi R, et al
    Local Control After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Tale of 2 Schedules?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  222. HARRIS DM, Popple RA, Jackson BF, Singh KP, et al
    Analysis of Predictive Factors for Pneumonitis in Lung Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  223. JOSEPH N, McWilliam A, Kennedy J, Faivre-Finn C, et al
    A Higher Integral Heart Dose Is Associated With Lymphocytopenia in Non-Small Cell Lung Cancer Patients Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  224. FEEHS K, Soike M, Russell G, Farris M, et al
    Difference in Demographics for Patients With Stage IIB-IIIB Non-Small Cell Lung Cancer Receiving Combined Modality Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  225. ADIL K, Boustead A, El Naqa I, Seuntjens J, et al
    Stereotactic Body Radiation Therapy With 48 Gy in 3 Fractions Is an Effective Treatment for Early-Stage Non-Small Cell Lung Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  226. RICE SR, Molitoris JK, Vyfhuis M, Mohindra P, et al
    Magnetic Resonance Imaging Brain Staging in Stage I-III Non-Small Cell Lung Cancer (NSCLC): Incidence and Clinicopathologic Factors in Asymptomatic Brain Metastases at Diagnosis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  227. BAZAN JG, Barney C, Scoville N, Haglund KE, et al
    Increased Posttreatment Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Marker for Worse Overall Survival in Patients Receiving Concurrent Chemoradiation for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  228. JOLLY S, Sun Y, Bi N, Tewari M, et al
    Using a Pretreatment Serum microRNA Signature to Identify Non-Small Cell Lung Cancer Patients Who Benefit From Radiation Dose Escalation.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  229. BLEDSOE TJ, Rutter CE, Lester-Coll NH, Bi X, et al
    Radiation to Oligoprogessive Sites of Disease Can Prolong the Duration of Response to Immune Checkpoint Inhibitors in Patients With Metastatic Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  230. JOO JH, Song SY, Park J, Choi EK, et al
    Lymphocyte Depletion by Radiation Therapy Alone Is Associated With Poor Survival in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  231. YOON S, Shaikh T, Ross EA, Bauman J, et al
    Patterns and Predictors of Failure Following Definitive Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer (NSCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  232. KING M, Kong FM, Campbell J, Goetz R, et al
    Cytokine Signature During Early Treatment May Predict Midtreatment Positron Emission Tomography/Computed Tomography and Survival in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  233. SURI JS, Bergsma DP, Moravan MJ, Usuki KY, et al
    Clinical Presentation and Distribution of Solitary Brain Metastases Among Non-Small Cell Lung Cancer (NSCLC) Patients in the Modern Staging Era.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  234. MA SJ, Gomez Suescun J, Wang K, Singh AK, et al
    Thoracic Radiation Therapy in Extensive-Stage Small Cell Lung Cancer: A Single-Institution Experience.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  235. HERSKOVIC A, Chitti BS, Christos P, Wernicke AG, et al
    Addition of Surgery After Radiation Significantly Improves Survival in Stage IIIB Non-Small Cell Lung Cancer: A Population-Based Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  236. ERGEN SA, Dincbas FO, Yucel B, Akyurek S, et al
    Risk Factors of Radiation Pneumonitis in the Patients With Non-Small Cell Lung Cancer Treated by Concomitant Chemoradiation Therapy: TOG/TROD Lung Cancer Study Group.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  237. ZHANG Y, Zanos P, Jackson I, Zhang X, et al
    Psychological Stress Enhances Tumor Growth and Diminishes Radiation Response in Preclinical Model of Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  238. HOBSON S, Abugharib A, Schipper M, Matuszak MM, et al
    Predictors of Acute Esophagitis in Lung Cancer Patients Treated With Definitive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  239. XU T, Fan J, Levy LB, Zhuang Y, et al
    Predictive Value of Serum Hepcidin for Disease Outcome in Non-Small Cell Lung Cancer Patients Received Definitive Radio(chemo)therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  240. PALMA DA, Kwan K, Gaede S, Landis M, et al
    A Phase II Trial Measuring the Integration of Stereotactic Ablative Radiation Therapy (SABR) Plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE-NSCLC): Interim Safety Results.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  241. JULOORI A, Vassil AD, Woody NM, Stephans KL, et al
    Managing Local Recurrence After Primary Resection of Non-Small Cell Lung Cancer: The Role for Salvage Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  242. VYFHUIS M, Bhooshan N, Feliciano J, Burrows W, et al
    Implications of Pathological Complete Response (pCR) at the Primary Tumor After Chemoradiation Therapy (CRT) Followed by Surgical Resection in Patients With Locally Advanced, Non-Small Cell Lung Cancer (LANSCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  243. CHITTI BS, Wernicke AG, Parashar B
    Radiation Therapy Improves Survival in Elderly Patients With Locally Advanced Non-Small Cell Lung Cancer: A Population-Based Analysis.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  244. SHEN S, Spencer SA, Singh SP
    Application of 4-Dimensional ECG-gated Computed Tomography for Planning Tumors Adjacent to the Heart for Radiation Therapy of Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  245. GAO S, Corso CD, Wang EH, Blasberg J, et al
    Timing of Surgery After Neoadjuvant Chemoradiation in Clinical Stage IIIA Non-Small Cell Lung Cancer With Mediastinal Nodal Involvement.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  246. FERRAZZA P, Menichelli C, Fanelli A, Grespi S, et al
    Thoracic Reirradiation After Previous Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer and Lung Metastases: The Role of Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  247. SMITH AW, Chitti BS, Wernicke AG, Parashar B, et al
    Increasing Use of Combination Surgery and Radiation Compared to Surgery or Radiation Alone Has Improved Survival in Patients With Stage IIIA Non-Small Cell Lung Cancer: A Population-Based Study of Patterns of Care.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  248. WALKER AL, Marwaha G, Bonomi P, Sher DJ, et al
    Toxicity and Efficacy of Thoracic Reirradiation With Split-Course Chemoradiation Therapy for the Curative Treatment of Recurrent Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  249. HIGGINS KA, Jia Y, Liu Y, Force S, et al
    Lung Stereotactic Body Radiation Therapy (SBRT) Versus Pneumonectomy in Patients With Non-Small Cell Lung Cancer (NSCLC) Ages 70 or Older.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  250. AKYUREK S, Ozdemir BS, Sert F, Yalman D, et al
    Radiation Therapy and Chemotherapy Results in Elderly Patients With Stage III Non-Small Cell Lung Cancer: Turkish Thoracic Radiation Oncology Group Study.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  251. BAINBRIDGE HE, Menten MJ, Fast MF, Nill S, et al
    Dosimetric Implications for Radical Radiation Therapy on the Magnetic Resonance-Linear Accelerator (MRL) in Locally Advanced Non-Small Cell Lung Cancer (LA NSCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  252. KOMAKI RU, Allen PK, Wei X, Welsh JW, et al
    Completing Thoracic Radiation Therapy With Concurrent Chemotherapy Within 6 weeks Is Important for Reducing Distant Disease in Patients With Limited-Stage Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  253. HANNA GG, Johnston RE, Eakin RL, Harney J, et al
    Consultant-Led Radiation Therapy Plan Peer Review Meeting and Improved Access to and Outcomes From Curative Intent Lung Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  254. SCHYTTE T, Nielsen TB, Brink C, Hansen O, et al
    Is Overall Survival in Non-Small Cell Lung Cancer Patients Treated With Definitive Radiation Therapy Affected by Dose to the Heart?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  255. APPEL S, Goldstein JD, Symon Z, Lawrence Y, et al
    Does Pathologic Response to Neoadjuvant Chemoradiation to 60 Gy Predict Survival in Locally Advanced Non-Small Cell Lung Cancer?
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  256. MEN Y, Hui Z, Wang X, Liang J, et al
    The Role of Postoperative Radiation Therapy (PORT) in Combined Small Cell Lung Cancer (C-SCLC).
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  257. ZHAO L, Wang S, Li-Ming X, Ren X, et al
    The Preliminary Results of Cytokine-Induced Killer Cells in Combination With Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  258. SU S, Ouyang W, Hu Y, Ma Z, et al
    Is Radiation Therapy in Addition to Chemotherapy Beneficial for Overall Survival in Patients With Nonoligometastatic Non-Small Cell Lung Cancer? Reanalysis of the Data of 2 Prospective Studies.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  259. NIELSEN TB, Nielsen M, Schytte T, Brink C, et al
    The Safety of Critical Structures Throughout Treatment for Dose-Escalated Locally Advanced Non-Small Cell Lung Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  260. ZHOU Y, Liu N, Dong Y, Huang Y, et al
    A Pilot Study of 18F-ALF-NOTA-PRGD2 PET/CT Imaging in Detecting Lymph Node Metastases in Patients With Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  261. GUO W, Gao XS, Ma MW, Han LJ, et al
    Hypofractionated Stereotactic Radiation Therapy for Advanced Non-Small Cell Lung Cancer: Report on Clinical Outcome and Toxicity.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  262. SHAFFER J, Negahdar M, von Eyben R, Diehn M, et al
    Four-Dimensional Computed Tomography Pulmonary Nodule Elastometry as a Predictor of Regional Recurrence Following Stereotactic Ablative Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  263. SHI A, You J, Wu Y, Yu H, et al
    A Dose Escalation Study With Intensity Modulated Radiation Therapy Using Simultaneous Integrated Boost for Limited-Disease Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  264. WONG AT, Schwartz D, Rineer JM, Safdieh J, et al
    The Impact of Thoracic Radiation Therapy Timing and Fractionation on Survival in Nonmetastatic Small Cell Lung Carcinoma Using the National Cancer Data Base.
    Int J Radiat Oncol Biol Phys. 2016;96.
    PubMed     Text format    


  265. SPERDUTO PW, Yang TJ, Beal K, Pan H, et al
    The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2016;96:406-13.
    PubMed     Text format     Abstract available


    September 2016
  266. VERMA V, McMillan MT, Grover S, Simone CB 2nd, et al
    Stereotactic Body Radiation Therapy and the Influence of Chemotherapy on Overall Survival for Large (>/=5 Centimeter) Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Sep 29. pii: S0360-3016(16)33247.
    PubMed     Text format     Abstract available


  267. MILLER JA, Bennett EE, Xiao R, Kotecha R, et al
    Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.
    Int J Radiat Oncol Biol Phys. 2016 Sep 1. pii: S0360-3016(16)33154.
    PubMed     Text format     Abstract available


    August 2016
  268. HEPEL JT, Leonard KL, Safran H, Ng T, et al
    Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study.
    Int J Radiat Oncol Biol Phys. 2016 Aug 31. pii: S0360-3016(16)33147.
    PubMed     Text format     Abstract available


  269. BI N, Shedden K, Zheng X, Kong FM, et al
    Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis.
    Int J Radiat Oncol Biol Phys. 2016;95:1378-90.
    PubMed     Text format     Abstract available


    July 2016
  270. VINOGRADSKIY Y, Schubert L, Diot Q, Waxweiller T, et al
    Regional Lung Function Profiles of Stage I and III Lung Cancer Patients: An Evaluation for Functional Avoidance Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;95:1273-80.
    PubMed     Text format     Abstract available


    June 2016
  271. ROSSI MM, Peulen HM, Belderbos JS, Sonke JJ, et al
    Intrafraction Motion in Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: Intensity Modulated Radiation Therapy Versus Volumetric Modulated Arc Therapy.
    Int J Radiat Oncol Biol Phys. 2016;95:835-43.
    PubMed     Text format     Abstract available


    May 2016
  272. VEIGA C, Janssens G, Teng CL, Baudier T, et al
    First Clinical Investigation of Cone Beam Computed Tomography and Deformable Registration for Adaptive Proton Therapy for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;95:549-59.
    PubMed     Text format     Abstract available


  273. CHANG JY, Jabbour SK, De Ruysscher D, Schild SE, et al
    Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;95:505-16.
    PubMed     Text format     Abstract available


  274. DUECK J, Knopf AC, Lomax A, Albertini F, et al
    Robustness of the Voluntary Breath-Hold Approach for the Treatment of Peripheral Lung Tumors Using Hypofractionated Pencil Beam Scanning Proton Therapy.
    Int J Radiat Oncol Biol Phys. 2016;95:534-41.
    PubMed     Text format     Abstract available


  275. GAMEIRO SR, Malamas AS, Bernstein MB, Tsang KY, et al
    Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing.
    Int J Radiat Oncol Biol Phys. 2016;95:120-30.
    PubMed     Text format     Abstract available


  276. MORI S, Karube M, Shirai T, Tajiri M, et al
    Carbon-Ion Pencil Beam Scanning Treatment With Gated Markerless Tumor Tracking: An Analysis of Positional Accuracy.
    Int J Radiat Oncol Biol Phys. 2016;95:258-66.
    PubMed     Text format     Abstract available


    April 2016
  277. PEULEN H, Mantel F, Guckenberger M, Belderbos J, et al
    Validation of High-Risk Computed Tomography Features for Detection of Local Recurrence After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Apr 12. pii: S0360-3016(16)30106.
    PubMed     Text format     Abstract available


  278. MILISAVLJEVIC S, Spasic M
    In Regard to Nagata et al.
    Int J Radiat Oncol Biol Phys. 2016;94:1219-20.
    PubMed     Text format    


    March 2016
  279. LANDAU DB, Hughes L, Baker A, Bates AT, et al
    IDEAL-CRT: A Phase 1/2 Trial of Isotoxic Dose-Escalated Radiation Therapy and Concurrent Chemotherapy in Patients With Stage II/III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016 Mar 28. pii: S0360-3016(16)00343.
    PubMed     Text format     Abstract available


  280. WU J, Gensheimer MF, Dong X, Rubin DL, et al
    Robust Intratumor Partitioning to Identify High-Risk Subregions in Lung Cancer: A Pilot Study.
    Int J Radiat Oncol Biol Phys. 2016 Mar 24. pii: S0360-3016(16)00330.
    PubMed     Text format     Abstract available


  281. KLEMENT RJ, Allgauer M, Andratschke N, Blanck O, et al
    Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases.
    Int J Radiat Oncol Biol Phys. 2016;94:841-9.
    PubMed     Text format     Abstract available


  282. BINKLEY MS, Hiniker SM, Chaudhuri A, Maxim PG, et al
    Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.
    Int J Radiat Oncol Biol Phys. 2016;94:808-15.
    PubMed     Text format     Abstract available


  283. LEE HW, Noh OK, Oh YT, Choi JH, et al
    Radiation Therapy-First Strategy After Surgery With or Without Adjuvant Chemotherapy in Stage IIIA-N2 Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;94:621-7.
    PubMed     Text format     Abstract available


  284. WARNER A, Dahele M, Hu B, Palma DA, et al
    Factors Associated With Early Mortality in Patients Treated With Concurrent Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;94:612-20.
    PubMed     Text format     Abstract available


  285. LEE D, Greer PB, Ludbrook J, Arm J, et al
    Audiovisual Biofeedback Improves Cine-Magnetic Resonance Imaging Measured Lung Tumor Motion Consistency.
    Int J Radiat Oncol Biol Phys. 2016;94:628-36.
    PubMed     Text format     Abstract available


  286. BODA-HEGGEMANN J, Knopf AC, Simeonova-Chergou A, Wertz H, et al
    Deep Inspiration Breath Hold-Based Radiation Therapy: A Clinical Review.
    Int J Radiat Oncol Biol Phys. 2016;94:478-92.
    PubMed     Text format     Abstract available


    February 2016
  287. SONG C, Hong BJ, Bok S, Lee CJ, et al
    Real-time Tumor Oxygenation Changes After Single High-dose Radiation Therapy in Orthotopic and Subcutaneous Lung Cancer in Mice: Clinical Implication for Stereotactic Ablative Radiation Therapy Schedule Optimization.
    Int J Radiat Oncol Biol Phys. 2016 Feb 13. pii: S0360-3016(16)00138.
    PubMed     Text format     Abstract available


  288. MAGNUSON WJ, Yeung JT, Guillod PD, Gettinger SN, et al
    Impact of Deferring Radiation Therapy in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Develop Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2016 Feb 2. pii: S0360-3016(16)00058.
    PubMed     Text format     Abstract available


  289. FRIED DV, Mawlawi O, Zhang L, Fave X, et al
    Potential Use of (18)F-fluorodeoxyglucose Positron Emission Tomography-Based Quantitative Imaging Features for Guiding Dose Escalation in Stage III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;94:368-76.
    PubMed     Text format     Abstract available


  290. VALLE LF, Jagsi R, Bobiak SN, Zornosa C, et al
    Variation in Definitive Therapy for Localized Non-Small Cell Lung Cancer Among National Comprehensive Cancer Network Institutions.
    Int J Radiat Oncol Biol Phys. 2016;94:360-7.
    PubMed     Text format     Abstract available


  291. FITZGERALD TJ, Bishop-Jodoin M, Followill DS, Galvin J, et al
    Imaging and Data Acquisition in Clinical Trials for Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2016;94:404-11.
    PubMed     Text format     Abstract available


  292. NIEDZIELSKI JS, Yang J, Stingo F, Martel MK, et al
    Objectively Quantifying Radiation Esophagitis With Novel Computed Tomography-Based Metrics.
    Int J Radiat Oncol Biol Phys. 2016;94:385-93.
    PubMed     Text format     Abstract available


  293. BRIERE TM, Krafft S, Liao Z, Martel MK, et al
    Lung Size and the Risk of Radiation Pneumonitis.
    Int J Radiat Oncol Biol Phys. 2016;94:377-84.
    PubMed     Text format     Abstract available


    January 2016
  294. JIANG Y, Verbiest T, Devery AM, Bokobza SM, et al
    Hypoxia Potentiates the Radiation-Sensitizing Effect of Olaparib in Human Non-Small Cell Lung Cancer Xenografts by Contextual Synthetic Lethality.
    Int J Radiat Oncol Biol Phys. 2016 Jan 23. pii: S0360-3016(16)00056.
    PubMed     Text format     Abstract available


  295. HORINOUCHI H, Goto Y, Kanda S, Fujiwara Y, et al
    Candidates for Intensive Local Treatment in cIIIA-N2 Non-Small Cell Lung Cancer: Deciphering the Heterogeneity.
    Int J Radiat Oncol Biol Phys. 2016;94:155-62.
    PubMed     Text format     Abstract available


  296. DEEK MP, Benenati B, Kim S, Chen T, et al
    Thoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2016;94:147-54.
    PubMed     Text format     Abstract available


  297. TAKAO S, Miyamoto N, Matsuura T, Onimaru R, et al
    Intrafractional Baseline Shift or Drift of Lung Tumor Motion During Gated Radiation Therapy With a Real-Time Tumor-Tracking System.
    Int J Radiat Oncol Biol Phys. 2016;94:172-80.
    PubMed     Text format     Abstract available


  298. MACKILLOP WJ, Kong W
    Estimating the Need for Palliative Radiation Therapy: A Benchmarking Approach.
    Int J Radiat Oncol Biol Phys. 2016;94:51-9.
    PubMed     Text format     Abstract available


    December 2015
  299. MATTONEN SA, Palma DA, Johnson C, Louie AV, et al
    Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
    Int J Radiat Oncol Biol Phys. 2015 Dec 29. pii: S0360-3016(15)27223.
    PubMed     Text format     Abstract available


  300. KELSEY CR, Das S, Gu L, Dunphy FR 3rd, et al
    Phase 1 Dose Escalation Study of Accelerated Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2015;93:997-1004.
    PubMed     Text format     Abstract available


  301. NAGATA Y, Hiraoka M, Shibata T, Onishi H, et al
    Prospective Trial of Stereotactic Body Radiation Therapy for Both Operable and Inoperable T1N0M0 Non-Small Cell Lung Cancer: Japan Clinical Oncology Group Study JCOG0403.
    Int J Radiat Oncol Biol Phys. 2015;93:989-996.
    PubMed     Text format     Abstract available


  302. KANG J, Schwartz R, Flickinger J, Beriwal S, et al
    Machine Learning Approaches for Predicting Radiation Therapy Outcomes: A Clinician's Perspective.
    Int J Radiat Oncol Biol Phys. 2015;93:1127-35.
    PubMed     Text format     Abstract available


    November 2015
  303. KARUBE M, Yamamoto N, Nakajima M, Yamashita H, et al
    Single-Fraction Carbon-Ion Radiation Therapy for Patients 80 Years of Age and Older With Stage I Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2015 Nov 30. pii: S0360-3016(15)26772.
    PubMed     Text format     Abstract available


  304. DOU TH, Thomas DH, O'Connell DP, Lamb JM, et al
    A Method for Assessing Ground-Truth Accuracy of the 5DCT Technique.
    Int J Radiat Oncol Biol Phys. 2015;93:925-33.
    PubMed     Text format     Abstract available


  305. YAMOAH K, Showalter TN, Ohri N
    Radiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized Trials.
    Int J Radiat Oncol Biol Phys. 2015;93:737-45.
    PubMed     Text format     Abstract available


  306. LIU W, Schild SE, Chang JY, Liao Z, et al
    Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2015 Nov 10. pii: S0360-3016(15)26684.
    PubMed     Text format     Abstract available


  307. HOPPE BS, Henderson R, Pham D, Cury JD, et al
    A Phase 2 Trial of Concurrent Chemotherapy and Proton Therapy for Stage III Non-Small Cell Lung Cancer: Results and Reflections Following Early Closure of a Single-Institution Study.
    Int J Radiat Oncol Biol Phys. 2015 Nov 10. pii: S0360-3016(15)26686.
    PubMed     Text format     Abstract available


  308. TIMMERMAN RD
    The Quality of Toxicity Reporting and the Story of the Lung SBRT "No-Fly Zone". In Regard to Oskan.
    Int J Radiat Oncol Biol Phys. 2015;93:726-7.
    PubMed     Text format    


  309. LI H, Zhu XR, Zhang X
    Reducing Dose Uncertainty for Spot-Scanning Proton Beam Therapy of Moving Tumors by Optimizing the Spot Delivery Sequence.
    Int J Radiat Oncol Biol Phys. 2015;93:547-56.
    PubMed     Text format     Abstract available


  310. MINATEL E, Trovo M, Bearz A, Di Maso M, et al
    Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.
    Int J Radiat Oncol Biol Phys. 2015;93:606-13.
    PubMed     Text format     Abstract available


  311. WESTHOFF PG, de Graeff A, Monninkhof EM, Pomp J, et al
    Quality of Life in Relation to Pain Response to Radiation Therapy for Painful Bone Metastases.
    Int J Radiat Oncol Biol Phys. 2015;93:694-701.
    PubMed     Text format     Abstract available


  312. LIU E, Santibanez P, Puterman ML, Weber L, et al
    A Quantitative Analysis of the Relationship Between Radiation Therapy Use and Travel Time.
    Int J Radiat Oncol Biol Phys. 2015;93:710-8.
    PubMed     Text format     Abstract available


    October 2015
  313. SIVA S, Hardcastle N, Kron T, Bressel M, et al
    Ventilation/Perfusion Positron Emission Tomography--Based Assessment of Radiation Injury to Lung.
    Int J Radiat Oncol Biol Phys. 2015;93:408-17.
    PubMed     Text format     Abstract available


  314. GOLDSTEIN JD, Lawrence YR, Appel S, Landau E, et al
    Continuous Positive Airway Pressure for Motion Management in Stereotactic Body Radiation Therapy to the Lung: A Controlled Pilot Study.
    Int J Radiat Oncol Biol Phys. 2015;93:391-9.
    PubMed     Text format     Abstract available


  315. DIN SU, Williams EL, Jackson A, Rosenzweig KE, et al
    Impact of Fractionation and Dose in a Multivariate Model for Radiation-Induced Chest Wall Pain.
    Int J Radiat Oncol Biol Phys. 2015;93:418-24.
    PubMed     Text format     Abstract available


  316. ALAM A, Mukhopadhyay ND, Ning Y, Reshko LB, et al
    A Preliminary Study on Racial Differences in HMOX1, NFE2L2, and TGFbeta1 Gene Polymorphisms and Radiation-Induced Late Normal Tissue Toxicity.
    Int J Radiat Oncol Biol Phys. 2015;93:436-43.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: